|
Sign In to gain access to subscriptions and/or personal tools.
|
Pathological Features of Spontaneous and Induced Tumors in Transgenic Mice Carrying a Human Prototype c-Ha-ras Gene Used for Six-Month Carcinogenicity Studies
Kunitoshi Mitsumori
Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158, Japan
Haruko Koizumi
Central Institute for Experimental Animals, 1430 Nogawa, Miyamae-kn, Kawasaki, Kanagawa 216, Japan
Tatsuji Nomura
Central Institute for Experimental Animals, 1430 Nogawa, Miyamae-kn, Kawasaki, Kanagawa 216, Japan
Satoshi Yamamoto
Department of Pharmacology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan
To validate the transgenic (Tg) mouse carrying a human prototype c-Ha-ras gene (rasH2 mouse) as a model for short or medium-term carcinogenicity testing, 6-mo carcinogenicity studies using more than 30 chemicals, including carcinogens and noncarcinogens, have been performed. The results obtained so far indicate that rasH2 mice are generally much more susceptible to both mutagenic and nonmutagenic carcinogens than are non-Tg mice, pointing to advantageous application for detection of carcinogenic potential. In this review, histopathological features and diagnostic criteria for spontaneous and induced-tumors observed in our 6-mo carcinogenicity studies are described. Incidences of spontaneous tumors were generally low in rasH2 mice during the 6-mo studies, although values for lung adenomas and splenic hemangiosarcomas were higher than those in the control non-Tg mice. A few forestomach papillomas and skin papillomas were also observed in the control rasH2 mice. The target organs in rasH2 mice treated with known carcinogens were not always identical to those in the treated B6C3F1 mice in 2-yr carcinogenicity bioassays, with forestomach squamous cell tumors, lung alveolar epithelial tumors and/or hemangiosarcomas in the spleen observed in addition to some but not all of the lesions in target organs observed in non-Tg mice in long-term carcinogenicity bioassays. The results of the present histological study suggest that the lung, spleen and/or forestomach, where tumors are induced in rasH2 mice treated with known carcinogens, should be regarded as informative target organs in addition to the target organs reported in previous long-term carcinogenicity bioassays in rats and mice.
Key Words: Human prototype c-Ha-ras transgenic mice • rasH2 mice • spontaneous tumors • induced tumors • 6-mo carcinogenicity testing • chemical carcinogenesis • carcinogens • morphology
Toxicologic Pathology, Vol. 26, No. 4,
520-531 (1998)
DOI: 10.1177/019262339802600408
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
T. Ohnishi, K. Fukamachi, Y. Ohshima, X. Jiegou, S. Ueda, M. Iigo, N. Takasuka, A. Naito, K.-i. Fujita, Y. Matsuoka, et al.
Possible Application of Human c-Ha-ras Proto-Oncogene Transgenic Rats in a Medium-Term Bioassay Model for Carcinogens
Toxicol Pathol,
April 1, 2007;
35(3):
436 - 443.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Okamura, M. Moto, M. Muguruma, T. Ito, M. Jin, Y. Kashida, and K. Mitsumori
A 26-Week Carcinogenicity Study of 2-Amino-3-Methylimidazo[4,5-f]Quinoline in rasH2 Mice
Toxicol Pathol,
February 1, 2006;
34(2):
199 - 205.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Nesfield, C. J. Clarke, D. J. Hoivik, R. T. Miller, J. S. Allen, K. Selinger, and M. J. Santostefano
Evaluation of the Carcinogenic Potential of Clofibrate in the rasH2 Mouse
International Journal of Toxicology,
September 1, 2005;
24(5):
301 - 311.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ozaki, K. Ozaki, T. Watanabe, S. Uwagawa, Y. Okuno, and T. Shirai
Susceptibilities of p53 Knockout and rasH2 Transgenic Mice to Urethane-Induced Lung Carcinogenesis are Inherited from their Original Strains
Toxicol Pathol,
February 1, 2005;
33(2):
267 - 271.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Curtin, M. A. Higuchi, P. H. Ayres, J. E. Swauger, and A. T. Mosberg
Lung Tumorigenicity in A/J and rasH2 Transgenic Mice Following Mainstream Tobacco Smoke Inhalation
Toxicol. Sci.,
September 1, 2004;
81(1):
26 - 34.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Toyosawa, K. Tanaka, T. Imai, K. Yasuhara, T. Koujitani, M. Hirose, and K. Mitsumori
Mutation and Overexpression of the Transgene in Ethylnitrosourea-Induced Tumors in Mice Carrying a Human Prototype c-Ha-ras Gene
Toxicol Pathol,
August 1, 2003;
31(5):
491 - 495.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Takaoka, S. Sehata, T. Maejima, T. Imai, M. Tor, H. Satoh, K. Toyosawa, Z.-Y. Tanakamaru, T. Adachi, S. Hisada, et al.
Interlaboratory Comparison of Short-Term Carcinogenicity Studies Using CB6F1-rasH2 Transgenic Mice
Toxicol Pathol,
February 1, 2003;
31(2):
191 - 199.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Sehata, T. Maejima, M. Watanabe, S. Ogata, T. Makino, K. Tanaka, S. Manabe, and M. Takaoka
Twenty-Six-Week Carcinogenicity Study of Chloroform in CB6F1 rasH2-Transgenic Mice
Toxicol Pathol,
April 1, 2002;
30(3):
328 - 338.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. Morton, C. L. Alden, A. J. Roth, and T. Usui
The Tg rasH2 Mouse in Cancer Hazard Identification
Toxicol Pathol,
January 1, 2002;
30(1):
139 - 146.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. Toyosawa, K. Okimoto, I. Kobayashi, K. Kijima, E. Kikawa, M. Kohchi, T. Koujitani, K. Tanaka, and N. Matsuoka
Di(2-ethylhexyl)phthalate Induces Hepatocellular Adenoma in Transgenic Mice Carrying a Human Prototype c-Ha-ras Gene in a 26-Week Carcinogenicity Study
Toxicol Pathol,
June 1, 2001;
29(4):
458 - 466.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N. Tamaoki
The rasH2 Transgenic Mouse: Nature of the Model and Mechanistic Studies on Tumorigenesis
Toxicol Pathol,
January 1, 2001;
29(1_suppl):
81 - 89.
[Abstract]
[PDF]
|
|
|
|
|
|
|
T. Usui, M. Mutai, S. Hisada, M. Takoaka, K. A. Soper, B. Mccullough, and C. Alden
CB6F1-rasH2 Mouse: Overview of Available Data
Toxicol Pathol,
January 1, 2001;
29(1_suppl):
90 - 108.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. F. Van Kreijl, P. A. Mcanulty, R. B. Beems, A. Vynckier, H. Van Steeg, R. Fransson-Steen, C. L. Alden, R. Forster, J.-W. Van der Laan, and J. Vandenberghe
Xpa and Xpa/p53+/- Knockout Mice: Overview of Available Data
Toxicol Pathol,
January 1, 2001;
29(1_suppl):
117 - 127.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. Takegawa, K. Mitsumori, K. Yasuhara, M. Moriyasu, M. Sakamori, H. Onodera, M. Hirose, and T. Nomura
A Mechanistic Study of Ovarian Carcinogenesis Induced by Nitrofurazone Using rasH2 Mice
Toxicol Pathol,
September 1, 2000;
28(5):
649 - 655.
[Abstract]
[PDF]
|
|
|
|
|
|
|
T. Ota, M. Asamoto, H. Toriyama-Baba, F. Yamamoto, Y. Matsuoka, T. Ochiya, T. Sekiya, M. Terada, H. Akaza, and H. Tsuda
Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis
Carcinogenesis,
July 1, 2000;
21(7):
1391 - 1396.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Gulezian, D. Jacobson-Kram, C. B. Mccullough, H. Olson, L. Recio, D. Robinson, R. Storer, R. Tennant, J. M. Ward, and D. A. Neumann
Review Article: Use of Transgenic Animals for Carcinogenicity Testing: Considerations and Implications for Risk Assessment
Toxicol Pathol,
May 1, 2000;
28(3):
482 - 499.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Asamoto, T. Ochiya, H. Toriyama-Baba, T. Ota, T. Sekiya, M. Terada, and H. Tsuda
Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis
Carcinogenesis,
February 1, 2000;
21(2):
243 - 249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. R. Maronpot
The Potential of Genetically Altered Mice as Animal Models for Carcinogen Identification
Toxicol Pathol,
July 1, 1998;
26(4):
579 - 581.
[PDF]
|
|
|
|
|
